|The information contained in TrialShare is made available as a service by the Immune Tolerance Network (ITN) in order to foster rapid dissemination of information among scientists.|
|Individuals not affiliated with the ITN and National Institute of Allergy and Infectious Disease (NIAID) can self-register and create an account in ITN TrialShare to access publicly released study data. You must be able to provide a valid e-mail address to successfully register with the system. If you are reviewing a manuscript submitted for publication you may be given an anonymous Manuscript Reviewer account by the system. Reviewers may access the relevant manuscript data only for the period of the review.|
|Access to Private Study Data|
|Public users can also request to become Collaborators and gain access to internally released studies by contacting email@example.com. However, Collaborator accounts are contingent upon approval by ITN Management. A Collaborator may be granted access to one or more internal studies containing data without all of the HIPAA defined Protected Health Information (PHI) removed. The information contained within the internally released studies in this system may be confidential and/or protected by copyright. As an Internal User or Collaborator, you agree to use the data responsibly and not use or disclose any PHI that would violate the HIPAA Privacy Rule.|
|Some of the system pages may provide links to other Internet sites only for the convenience of the users. ITN is not responsible for the availability or content of these external sites, nor does the ITN endorse, warrant or guarantee the products, services or information described or offered at these other Internet sites.|
|External Links to Applications Referencing, Displaying or Reporting ITN DATA|
|Some of the ITN TrialShare pages may provide links to other applications related to ITN data only for the convenience of the users. ITN is not responsible for the availability or content of these external sites, nor does the ITN endorse, warrant or guarantee the accuracy of results or methodology used by these systems.|
|Terms and Conditions for Your Use of ITN TrialShare|
|Authorization for use of the system requires your agreement to the following terms and conditions:
Users of ITN TrialShare are solely responsible for the accuracy of any use of the data derived from the system; any publication using information contained within the system must comply with the ITN publication policy, available at http://www.immunetolerance.org/PublicationsPolicy.
Nothing in this Agreement constitutes, expressly or by implication, a grant of a license or other rights to you by the ITN or NIAID.
|Data and Analyses|
ITN and NIAID do not individually or collectively make any representations that data or analyses available at ITN TrialShare are suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
Only ITN TrialShare users may access or acquire protocol study data through the system. Distribution of data acquired through ITN TrialShare to non-authorized users is strictly prohibited.
ITN is committed to transparency and will provide the source code to analytical approaches for reports and visualizations posted on ITN TrialShare either directly on the system or upon request. While ITN cannot make any guarantees as to the accuracy or completeness of data or analyses provided, we are available to discuss any related questions or concerns and will make a good faith effort to address any inquiries sent to firstname.lastname@example.org.
Each published manuscript follows statistical methods developed by the manuscript specific analysis team. Different manuscripts may utilize differing techniques and statistical approaches. Examples include: taking a log transformation instead of using the original scale, imputation of missing data, and varying start/end times for time to event analyses. Moreover, supplemental analyses are frequently performed as part of hypothesis generation as well as to inform various manuscript development projects. Each manuscript is therefore the definitive source of information concerning the analyses actually performed for that publication, and results may vary from other related manuscripts and analyses.
|Acknowledgement of ITN TrialShare|
If you intend to publish any data or research results acquired from a public data area of ITN TrialShare, you will, in accordance with scientific custom, acknowledge ITN TrialShare in the publication by citation, acknowledgement, or co-authorship.
If you publish a manuscript or article that describes data or the results of research derived from data acquired at ITN TrialShare, the ITN would greatly appreciate receiving an e-mail that contains the citation so that it can be listed in the Manuscripts and Abstracts section of the website.
Please send the citation by email to email@example.com.
|Warranties and Liability|
Data available at ITN TrialShare are provided on an "AS IS" basis. ITN and NIAID make no representations with respect to data completeness or accuracy. DATA ARE PROVIDED TO YOU WITH NO WARRANTIES, EXPRESS OR IMPLIED, no liability or indemnification for any loss, claim, or damage, (including but not limited to loss of data) is intended or provided by the ITN or NIAID under this Agreement.